Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Analytical Chemistry|March 18, 2021
A Computationally Lightweight Algorithm for Deriving Reliable Metabolite Panel Measurements from 1D <sup>1</sup>H NMRPanteleimon G Takis, Beatriz Jiménez, Nada M S Al-Saffar, et al.
Cancer Research|April 19, 2005
Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibitionMounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Oncotarget|June 19, 2017
Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopyAlice Agliano, Geetha Balarajah, Daniela M Ciobota, et al.
Molecular Cancer Therapeutics|January 25, 2006
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cellsMounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Cancer Research|June 17, 2010
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopyNada M S Al-Saffar, L Elizabeth Jackson, Florence I Raynaud, et al.
BMC Research Notes|May 25, 2012
Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance SpectroscopyLoreta M Rodrigues, Yuen-Li Chung, Nada M S Al Saffar, et al.
Plos One|July 14, 2017
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cellsNada M S Al-Saffar, Alice Agliano, Lynley V Marshall, et al.
Plos One|August 2, 2014
Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastomaNada M S Al-Saffar, Lynley V Marshall, L Elizabeth Jackson, et al.
Cancer Research|January 7, 2006
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma modelsNada M S Al-Saffar, Helen Troy, Ana Ramírez de Molina, et al.
British Journal of Cancer|November 1, 2018
Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinomaNada M S Al-Saffar, Helen Troy, Anne-Christine Wong Te Fong, et al.
Pageof 2